US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

9.30

-0.2850-2.97%

Post-market: 9.300.00000.00%16:10 EDT

Volume:145.76K

Turnover:1.36M

Market Cap:736.53M

PE:-0.03

High:9.87

Open:9.50

Low:9.00

Close:9.59

52wk High:12.50

52wk Low:8.50

Shares:79.20M

Float Shares:44.60M

Volume Ratio:0.71

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-268.5581

EPS(LYR):-511.8002

ROE:--

ROA:--

PB:-3.23

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BBOT to Participate in Upcoming September Investor Healthcare Conferences

Wedbush Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Initiated at Outperform by Wedbush

Wedbush Initiates BridgeBio Oncology Therapeutics at Outperform With $25 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBOT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":9.3,"timestamp":1756324800000,"preClose":9.585,"halted":0,"volume":145759,"hourTrading":{"tag":"盘后","latestPrice":9.3,"preClose":9.3,"latestTime":"16:10 EDT","volume":19,"amount":176.7,"timestamp":1756325403594},"delay":0,"floatShares":44603977,"shares":79196700,"eps":-268.55814,"marketStatus":"Closed","change":-0.285,"latestTime":"08-27 16:00:00 EDT","open":9.499,"high":9.8703,"low":9,"amount":1361928.3246,"amplitude":0.090798,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-268.55814,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756368000000},"marketStatusCode":5,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":9.585,"postHourTrading":{"tag":"盘后","latestPrice":9.3,"preClose":9.3,"latestTime":"16:10 EDT","volume":19,"amount":176.7,"timestamp":1756325403594},"volumeRatio":0.705102},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":44603977,"roa":"--","roe":"--","lyrEps":-511.800172,"volumeRatio":0.705102,"shares":79196700,"dividePrice":0,"high":9.8703,"amplitude":0.090798,"preClose":9.585,"low":9,"week52Low":8.5,"pbRate":"-3.23","week52High":12.5,"institutionHeld":0,"latestPrice":9.3,"eps":-268.55814,"divideRate":0,"volume":145759,"delay":0,"ttmEps":-268.55814,"open":9.499,"prevYearClose":10.5,"prevWeekClose":8.84,"prevMonthClose":10.6,"prevQuarterClose":10.62,"fiveDayClose":9.63,"twentyDayClose":10.71,"sixtyDayClose":10.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1756267200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2025-08-26","current":-9.59351,"percent":0.4,"low":-11.935077,"twenty":-10.077631,"median":-9.56881,"eighty":-9.514469,"high":-8.733947,"avg":-9.89979,"sd":0.9918,"marketCap":839432092},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-26","current":-9.59351,"twenty":-10.077631,"median":-9.56881,"eighty":-9.514469,"marketCap":839432092}],"updateTime":1756339296689},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560103964","title":"BBOT to Participate in Upcoming September Investor Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2560103964","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560103964?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:00","pubTimestamp":1755691200,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Aug.  20, 2025  (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malign","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/20/3136340/0/en/BBOT-to-Participate-in-Upcoming-September-Investor-Healthcare-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU2111349929.HKD","LU0971096721.USD","LU2028103732.USD","LU1720051017.SGD","LU2133065610.SGD","LU1989772840.SGD","BK4588","HCSG","LU1732800096.USD","LU1720051108.HKD","BK4534","LU2089284900.SGD","LU0006306889.USD","LU2347655156.SGD","LU0225283273.USD","LU0158827948.USD","LU0106261372.USD","BK4504","LU1548497426.USD","BK4585","LU2089283258.USD","LU2271345857.HKD","LU0158827781.USD","LU1162221912.USD","LU2023251221.USD","LU0795875169.SGD","IE00BZ1G4Q59.USD","LU1668664300.SGD","LU0314104364.USD","LU1244550494.USD","BK4581","LU2357305700.SGD","LU1732799900.SGD","LU0098860793.USD","IE00BKVL7J92.USD","LU0267386448.USD","LU1989772923.USD","LU0234570918.USD","LU0912757837.SGD","BK4137","LU1363072403.SGD","BK4516","LU1244550221.USD","BBOT","LU1074936037.SGD","LU0106831901.USD","LU0795875086.SGD","BK4127","LU0320765646.SGD"],"gpt_icon":0},{"id":"2560668061","title":"Wedbush Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560668061","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560668061?lang=en_us&edition=fundamental","pubTime":"2025-08-19 15:45","pubTimestamp":1755589517,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten reiterated a Buy rating on BridgeBio Oncology Therapeutics yesterday and set a price target of $25.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT"],"gpt_icon":0},{"id":"2560818613","title":"BridgeBio Oncology Initiated at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2560818613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560818613?lang=en_us&edition=fundamental","pubTime":"2025-08-18 22:40","pubTimestamp":1755528000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBOT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 18, 2025 10:40 ET (14:40 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT"],"gpt_icon":0},{"id":"2560901666","title":"Wedbush Initiates BridgeBio Oncology Therapeutics at Outperform With $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2560901666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560901666?lang=en_us&edition=fundamental","pubTime":"2025-08-18 19:06","pubTimestamp":1755515208,"startTime":"0","endTime":"0","summary":"Wedbush Initiates BridgeBio Oncology Therapeutics at Outperform With $25 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BBOT"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBOT\",params:#limit:6,delay:false,,,undefined,":[]}}